Tempus AI TEM
US equityMarket cap rank #1424Health Information ServicesAI application softwareAI medical concept stocks
$54.04 −$5.57 (-9.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $54.93 +1.65%
Open$57.78
Prev close$59.61
Day range$53.26 – $58.35
Volume7.44M
Market cap$9.86B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$411.54M+23.1% YoY
Operating profit-$56.86M+6.8% YoY
Net profit-$14.85M+81.4% YoY
Diluted EPS-$0.08+82.6% YoY
Free cash flow-$5.54M+95.7% YoY
Operating cash flow$9.22M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin64.5%
Operating margin-18.5%
Net margin-12.5%
Return on equity-37.5%
Return on assets-8.0%
Return on invested capital-8.5%
Current ratio2.61
Liabilities / assets79.6%
Cash & investments$637.35M
Total debt$1.42B
Net cash (debt)-$782.97M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $411.54M | $382.49M | $348.12M | $1.27B | $367.21M |
| Total Operating Revenue | $411.54M | $382.49M | $348.12M | $1.27B | $367.21M |
| Cost of Revenue | $144.84M | $135.99M | $126.08M | $473.89M | $129.50M |
| Gross Profit | $266.70M | $246.50M | $222.04M | $797.90M | $237.71M |
| Operating Expense | $323.57M | $322.41M | $306.75M | $1.05B | $299.13M |
| Selling and Admin Expenses | $231.86M | $225.85M | $212.59M | $715.43M | $192.20M |
| Research & Development | $91.71M | $96.57M | $94.16M | $319.03M | $90.62M |
| Operating Profit | -$56.86M | -$75.91M | -$84.71M | -$252.87M | -$61.41M |
| Net Non-Operating Interest Income (Expense) | -$2.72M | -$6.39M | -$10.48M | -$57.64M | -$10.16M |
| Non-Operating Interest Income | $3.99M | $3.90M | $3.87M | $12.63M | $5.12M |
| Non-Operating Interest Expense | $6.70M | $10.28M | $14.34M | $70.27M | $15.29M |
| Other Income (Expense) | $47.13M | $91.11M | -$27.71M | $19.41M | $14.57M |
| Special Income (Charges) | $0.00 | -$11.64M | – | -$12.03M | $0.00 |
| Other Non-Operating Income (Expenses) | $47.13M | $102.76M | -$27.71M | $31.45M | $14.57M |
| Pretax Profit | -$12.45M | $8.82M | -$122.90M | -$291.10M | -$57.01M |
| Tax | $35,000.00 | $309,000.00 | -$62,000.00 | -$51.68M | -$5.99M |
| $2.37M | $2.86M | $3.09M | $5.61M | $3.15M | |
| Net Profit | -$14.85M | $5.64M | -$125.92M | -$245.03M | -$54.17M |
| Profit from Continuing Operations | -$14.85M | $5.64M | -$125.92M | -$245.03M | -$54.17M |
| Net Income to Parent Company | -$14.85M | $5.64M | -$125.92M | -$245.03M | -$54.17M |
| Net Income to Common Stockholders | -$14.85M | $5.64M | -$125.92M | -$245.03M | -$54.17M |
| Basic EPS | -$0.08 | $0.03 | -$0.70 | -$1.41 | -$0.31 |
| Diluted EPS | -$0.08 | $0.03 | -$0.71 | -$1.41 | -$0.31 |
| -Less:Other Special Charges | – | $11.64M | – | $12.03M | $0.00 |
| Depreciation & Amortization & Depletion | – | – | – | $16.31M | – |
| -Depreciation & Amortization | – | – | – | $16.31M | – |
| Other Preferred Stock Dividends | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $2.45B | $2.37B | $2.14B | $2.27B | $2.27B |
| Total Current Assets | $1.14B | $1.29B | $1.05B | $1.17B | $1.17B |
| Cash and Cash Equivalents & Short-Term Investments | $637.35M | $815.99M | $639.07M | $755.00M | $755.00M |
| -Cash and Cash Equivalents | $590.48M | $599.61M | $521.17M | $604.79M | $604.79M |
| -Short Term Investments | $46.87M | $216.38M | $117.90M | $150.21M | $150.21M |
| Receivables | $398.24M | $378.42M | $320.51M | $319.96M | $319.96M |
| -Accounts Receivable | $380.74M | $360.92M | $308.60M | $311.17M | $311.17M |
| -Due from Related Parties Current | $17.50M | $17.50M | $11.91M | $8.79M | $8.79M |
| Inventory | $53.77M | $53.51M | $51.83M | $51.72M | $51.72M |
| Other Current Assets | $47.51M | $42.94M | $42.53M | $40.50M | $40.50M |
| Total Non-Current Assets | $1.31B | $1.08B | $1.08B | $1.11B | $1.11B |
| Net PPE | $153.59M | $149.62M | $150.90M | $153.65M | $153.65M |
| -Gross PPE | $311.99M | $300.68M | $294.85M | $291.00M | $291.00M |
| -Accumulated Depreciation | -$158.40M | -$151.07M | -$143.96M | -$137.35M | -$137.35M |
| Investments and Advances | $307.41M | $86.56M | $81.68M | $86.56M | $86.56M |
| -Available for Sale Securities | $212.28M | – | – | – | – |
| -Long Term Equity Investment | $77.64M | $77.81M | $81.68M | $86.56M | $86.56M |
| Non Current Accounts Receivables | $10.21M | $14.58M | $13.09M | $16.22M | $16.22M |
| Goodwill and Other Intangible Assets | $822.52M | $802.40M | $810.26M | $825.46M | $825.46M |
| -Goodwill | $488.14M | $470.17M | $470.17M | $470.21M | $470.21M |
| -Other Intangible Assets | $334.38M | $332.23M | $340.09M | $355.25M | $355.25M |
| Other Non-Current Assets | $21.00M | $21.89M | $25.22M | $25.78M | $25.78M |
| Total Liabilities | $1.95B | $1.92B | $1.72B | $1.78B | $1.78B |
| Total Current Liabilities | $436.41M | $391.49M | $317.96M | $372.39M | $372.39M |
| Payables | $80.51M | $83.82M | $41.02M | $82.33M | $82.33M |
| -Accounts Payable | $70.51M | $73.82M | $41.02M | $81.99M | $81.99M |
| -Due to Related Parties Current | $10.00M | $10.00M | – | – | – |
| Current Accrued Expenses | $184.21M | $135.07M | $126.08M | $121.61M | $121.61M |
| Short-Term Debt and Capital Lease Obligation | $11.58M | $12.19M | $12.64M | $13.36M | $13.36M |
| -Current Capital Lease Obligation | $11.58M | $12.19M | $12.64M | $13.36M | $13.36M |
| Current Deferred Liabilities | $97.90M | $103.21M | $88.82M | $108.63M | $108.63M |
| Other Current Liabilities | $12.15M | $8.29M | $10.25M | $8.68M | $8.68M |
| Total Non-Current Liabilities | $1.51B | $1.53B | $1.40B | $1.41B | $1.41B |
| Long Term Accounts Payable and Other Payables | $22.50M | $19.16M | $15.84M | $12.39M | $12.39M |
| Long Term Debt and Capital Lease Obligation | $1.42B | $1.43B | $1.31B | $1.31B | $1.31B |
| -Long Term Debt | $1.35B | $1.36B | $1.23B | $1.24B | $1.24B |
| -Long Term Capital Lease Obligation | $69.48M | $71.27M | $72.72M | $74.27M | $74.27M |
| Non-Current Deferred Liabilities | $20.51M | $22.08M | $24.88M | $28.36M | $28.36M |
| Convertible preferred securities | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Liabilities | $51.45M | $56.27M | $54.12M | $56.60M | $56.60M |
| Total Equity | $500.40M | $444.93M | $416.41M | $491.33M | $491.33M |
| Stockholders' Equity | $500.40M | $444.93M | $416.41M | $491.33M | $491.33M |
| Capital Stock | $19,000.00 | $19,000.00 | $18,000.00 | $18,000.00 | $18,000.00 |
| -Common Stock | $19,000.00 | $19,000.00 | $18,000.00 | $18,000.00 | $18,000.00 |
| Additional Paid-In Capital | $3.04B | $2.97B | $2.95B | $2.89B | $2.89B |
| Retained Earnings | -$2.53B | -$2.52B | -$2.52B | -$2.40B | -$2.40B |
| Less: Treasury Stock | -$6.64M | -$6.64M | -$6.64M | -$6.64M | -$6.64M |
| Gains/Losses Not Affecting Retained Earnings | $166,000.00 | -$1.94M | -$908,000.00 | $902,000.00 | $902,000.00 |
| -Total Tax Payable | – | – | – | $339,000.00 | $339,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $9.22M | -$7.53M | -$73.28M | -$218.09M | -$36.79M |
| Net cash flow from continuing operations | $9.22M | -$7.53M | -$73.28M | -$218.09M | -$36.79M |
| Net Income from Continuing Operations | -$14.85M | $5.64M | -$125.92M | -$245.03M | -$54.17M |
| Gain/Loss from Continuing Operations | -$40.31M | -$82.85M | $34.56M | $1.59M | -$8.18M |
| Depreciation & Depletion & Amortization | $26.23M | $25.99M | $26.18M | $102.32M | $26.91M |
| Deferred Tax | $0.00 | $0.00 | $0.00 | -$52.67M | -$6.45M |
| Other Non-Cash Items | $6.55M | $5.21M | $6.77M | $25.59M | $5.48M |
| Change in Working Capital | -$17.77M | -$16.04M | -$68.43M | -$178.55M | -$47.71M |
| -Change in Receivables | -$21.27M | -$52.56M | $1.99M | -$90.40M | -$27.20M |
| -Change in Inventory | $28,000.00 | -$1.86M | -$332,000.00 | -$3.37M | $3.17M |
| -Change in Prepaid Assets | -$4.56M | -$408,000.00 | -$2.03M | -$1.70M | $2.29M |
| -Change in Payables and Accrued Expense | $22.01M | $36.04M | -$41.63M | -$2.91M | $6.78M |
| -Change in Other Current Assets | $5.30M | $3.44M | $433,000.00 | -$42.30M | -$601,000.00 |
| -Change in Other Current Liabilities | -$3.64M | -$3.55M | -$3.58M | -$14.95M | -$3.80M |
| -Change In Other Working Capital | -$15.63M | $2.84M | -$23.29M | -$22.92M | -$28.35M |
| Net cash flow from investing | -$17.52M | -$11.09M | -$10.07M | -$398.36M | -$10.72M |
| Net Cash Flow from Continuing Investing Activities | -$17.52M | -$11.09M | -$10.07M | -$398.36M | -$10.72M |
| Capital Expenditure | -$5.42M | -$4.97M | -$1.87M | -$6.22M | -$1.58M |
| Net PPE Purchase and Sale | -$9.34M | -$6.13M | -$8.20M | -$21.05M | -$4.76M |
| Net Business Purchase and Sale | -$2.76M | $0.00 | $0.00 | -$376.67M | -$1.64M |
| Net Investment Purchase and Sale | $0.00 | $0.00 | $0.00 | $5.58M | -$2.74M |
| Financing Cash Flow | -$715,000.00 | $97.12M | -$271,000.00 | $884.12M | -$3.61M |
| Net Cash Flow from Continuing Financing Activities | -$715,000.00 | $97.12M | -$271,000.00 | $884.12M | -$3.61M |
| Net Issuance Payments Of Debt | -$100.00M | $228.98M | $0.00 | $735.76M | $0.00 |
| Net Common Stock Issuance | $100.00M | – | – | $192.46M | -$3.04M |
| Net Other Financing Charges | -$715,000.00 | -$31.86M | -$271,000.00 | -$44.10M | -$569,000.00 |
| Ending Cash Balance | $595.23M | $604.34M | $525.86M | $609.45M | $609.45M |
| Net Change in Cash | -$9.02M | $78.50M | -$83.62M | $267.68M | -$51.11M |
| Beginning Cash Balance | $604.34M | $525.86M | $609.45M | $341.84M | $660.55M |
| Effect of Exchange Rate Changes | -$84,000.00 | -$30,000.00 | $28,000.00 | -$62,000.00 | $16,000.00 |
| Free Cash Flow | -$5.54M | -$18.62M | -$83.34M | -$245.36M | -$43.12M |
| Net Preferred Stock Issuance | – | – | – | $0.00 | $0.00 |
| Cash Dividends Paid | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on TEM.
Sign in to join the discussion.